Pages that link to "Q38419194"
Jump to navigation
Jump to search
The following pages link to Recent advancement of molecular mechanisms of liver fibrosis (Q38419194):
Displaying 50 items.
- Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis (Q26744190) (← links)
- Role and New Insights of Pirfenidone in Fibrotic Diseases (Q26774154) (← links)
- Interleukin-1 Family Cytokines in Liver Diseases (Q26778553) (← links)
- Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B (Q30384757) (← links)
- Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation (Q35908145) (← links)
- Low Cardiac Output Leads Hepatic Fibrosis in Right Heart Failure Model Rats. (Q35919808) (← links)
- Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR (Q36173223) (← links)
- Establishment and characterization of an immortalized rat hepatic stellate cell line (Q36375017) (← links)
- α-Smooth muscle actin is an inconsistent marker of fibroblasts responsible for force-dependent TGFβ activation or collagen production across multiple models of organ fibrosis (Q36902380) (← links)
- Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells (Q37214779) (← links)
- Effects of recombinant human adenovirus-p53 on the regression of hepatic fibrosis (Q37269913) (← links)
- Interleukin-22 ameliorates liver fibrosis through miR-200a/beta-catenin (Q37397471) (← links)
- Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review. (Q38635618) (← links)
- Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis (Q38684604) (← links)
- New Insights into the Role of Autophagy in Ovarian Cryopreservation by Vitrification. (Q38748721) (← links)
- The protective effects of Masson pine pollen aqueous extract on CCl4-induced oxidative damage of human hepatic cells (Q38803397) (← links)
- Status of and candidates for cell therapy in liver cirrhosis: overcoming the "point of no return" in advanced liver cirrhosis (Q38820953) (← links)
- Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use Treatment (Q38927192) (← links)
- Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets (Q39084507) (← links)
- LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression (Q40324906) (← links)
- Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study (Q40615522) (← links)
- Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis (Q41519742) (← links)
- Ameliorative Effects of Nilotinib on CCl4 Induced Liver Fibrosis Via Attenuation of RAGE/HMGB1 Gene Expression and Oxidative Stress in Rat. (Q42223709) (← links)
- Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression (Q47122280) (← links)
- 3-Methyladenine ameliorates liver fibrosis through autophagy regulated by the NF-κB signaling pathways on hepatic stellate cell (Q47168911) (← links)
- α-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis. (Q47213785) (← links)
- Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses. (Q49351623) (← links)
- Interleukin‑10 promotes primary rat hepatic stellate cell senescence by upregulating the expression levels of p53 and p21. (Q50047726) (← links)
- Effects of joint immobilization on changes in myofibroblasts and collagen in the rat knee contracture model. (Q51027979) (← links)
- Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. (Q51546726) (← links)
- Histone methylation regulates Hif-1 signaling cascade in activation of hepatic stellate cells. (Q52365063) (← links)
- PPARγ Antagonizes Hypoxia-Induced Activation of Hepatic Stellate Cell through Cross Mediating PI3K/AKT and cGMP/PKG Signaling. (Q52568319) (← links)
- Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury. (Q55020270) (← links)
- Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis (Q58754397) (← links)
- Host Regulators of Liver Fibrosis During Human Schistosomiasis (Q59804799) (← links)
- Selective abdominal venous congestion induces adverse renal and hepatic morphological and functional alterations despite a preserved cardiac function (Q60045812) (← links)
- The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis (Q60911645) (← links)
- rSJYB1 inhibits collagen type I protein expression in hepatic stellate cells via down-regulating activity of collagen α1 (I) promoter (Q64071157) (← links)
- Accumulation of free cholesterol and oxidized low-density lipoprotein is associated with portal inflammation and fibrosis in nonalcoholic fatty liver disease (Q64085697) (← links)
- Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways. (Q64921355) (← links)
- Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study (Q87135867) (← links)
- Liver fibrosis (Q87669646) (← links)
- Severe Neonatal Hyperbilirubinemia in Crigler-Najjar Syndrome Model Mice Can Be Reversed With Zinc Protoporphyrin (Q87686309) (← links)
- A combination of astragaloside I, levistilide A and calycosin exerts anti-liver fibrosis effects in vitro and in vivo (Q88924934) (← links)
- Gut Microbial Dysbiosis Is Associated With Profibrotic Factors in Liver Fibrosis Mice (Q89823558) (← links)
- The Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer (Q90232767) (← links)
- Innate Immunity and Pathogenesis of Biliary Atresia (Q90248456) (← links)
- 2-Methoxyestradiol attenuates liver fibrosis in mice: implications for M2 macrophages (Q90393375) (← links)
- Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice (Q90574419) (← links)
- Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases (Q90643321) (← links)